Kenneth Kin Wah To
9PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Dec 02, 2025
KSQ-4279, an Inhibitor of Ubiquitin Specific Peptidase 1, Enhanced the Chemotherapeutic Efficacy in ABCB1/ABCG2/ABCC1-Mediated Multidrug Resistant Cancers.Qihong Yang, Kewang Luo, Kenneth Kin Wah To
|Jul 30, 2025
Recent Advances in the Use of <i>Ganoderma lucidum</i> and <i>Coriolus versicolor</i> Mushrooms to Enhance the Anticancer Efficacy of EGFR-Targeted Drugs in Lung Cancer.Hang Zhang, Longling Wang, Yuet Wa Chan
|Oct 30, 2024
Serum creatine kinase elevation following tyrosine kinase inhibitor treatment in cancer patients: Symptoms, mechanism, and clinical management.Hang Zhang, Kenneth K W To
|Oct 19, 2023
Circumvention of Gefitinib Resistance by Repurposing Flunarizine via Histone Deacetylase Inhibition.Kenneth K W To, James C H Chow, Ka-Man Cheung
|Aug 26, 2023
Drug Repurposing to Circumvent Immune Checkpoint Inhibitor Resistance in Cancer Immunotherapy.Kenneth K W To, William C Cho
|Apr 13, 2023
BET Bromodomain Inhibitors: Novel Design Strategies and Therapeutic Applications.Kenneth K W To, Enming Xing, Ross C Larue
Pageof 2
